Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous Infusion of Levofolinate and 5-FU in First-line Advanced Colorectal Cancer
NCT07391618Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- May 2025
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of levoleucovorin, fluorouracil in colorectal cancer (CRC), sponsored by Chinese PLA General Hospital. Started May 2025; status: recruiting.
02
Drugs
levoleucovorinfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07391618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391618.